WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018012889) COMPOSITION INCLUDING ITAC INHIBITOR
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/012889    International Application No.:    PCT/KR2017/007484
Publication Date: 18.01.2018 International Filing Date: 12.07.2017
IPC:
A61K 39/395 (2006.01), G01N 33/68 (2006.01)
Applicants: AMOREPACIFIC CORPORATION [KR/KR]; 106, Hangang-daero, Yongsan-gu, Seoul 04386 (KR)
Inventors: CHOI, Suh-Yeon; (KR).
CHO, Eun-Gyung; (KR).
BIN, Bum-Ho; (KR).
LEE, Tae Ryong; (KR)
Agent: KIM, Sun-young; (KR)
Priority Data:
10-2016-0088538 13.07.2016 KR
10-2017-0083366 30.06.2017 KR
Title (EN) COMPOSITION INCLUDING ITAC INHIBITOR
(FR) COMPOSITION COMPRENANT UN INHIBITEUR D'ITAC
(KO) ITAC의 억제제를 포함하는 조성물
Abstract: front page image
(EN)The present specification describes and relates to a composition for preventing or treating vitiligo or vitiligo metastasis, wherein the composition includes an interferon-inducible T-cell alpha chemoattractant (ITAC) inhibitor. The composition may inhibit the movement of melanin-forming cells and exhibit a hypopigmentation effect by inhibiting the activity of ITAC. Moreover, the composition may exhibit a vitiligo or vitiligo metastasis prevention or treatment effect by inhibiting ITAC activity.
(FR)La présente invention concerne et décrit une composition destinée à prévenir ou à traiter le vitiligo ou le vitiligo associé à un mélanome métastatique, la composition comprenant un inhibiteur de chimio-attracteur alpha des lymphocytes T induit par l'interféron (ITAC). La composition peut inhiber le déplacement des cellules formant la mélanine et présenter un effet d'hypopigmentation par inhibition de l'activité de l'ITAC. De plus, la composition peut présenter un effet de prévention ou de traitement du vitiligo ou du vitiligo associé à un mélanome métastatique par inhibition de l'activité de l'ITAC.
(KO)본 명세서는 인터페론-유도성 T-세포 알파 화학주성인자(interferon-inducible T-cell alpha chemoattractant; ITAC) 억제제를 포함하는 백반증 또는 백반증 전이의 예방 또는 치료용 조성물에 관하여 기술한다. 상기 조성물은 ITAC의 작용을 억제하여 멜라닌형성세포 이동을 억제하고 저색소침착 효과를 나타낼 수 있다. 또한 상기 조성물은 ITAC 작용을 억제하여 백반증 또는 백반증 전이의 예방 또는 치료 효과를 나타낼 수 있다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)